HEADER TRANSFERASE 29-AUG-12 4GU9 TITLE FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH (2-FLUORO- TITLE 2 PHENYL)-(1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-YL)-AMINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: FOCAL ADHESION KINASE 1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: CATALYTIC PROTEIN KINASE DOMAIN RESIDES 410-686; COMPND 5 SYNONYM: FADK 1, FOCAL ADHESION KINASE-RELATED NONKINASE, FRNK, COMPND 6 PROTEIN PHOSPHATASE 1 REGULATORY SUBUNIT 71, PPP1R71, PROTEIN- COMPND 7 TYROSINE KINASE 2, P125FAK, PP125FAK; COMPND 8 EC: 2.7.10.2; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PTK2, FAK, FAK1; SOURCE 6 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 7 EXPRESSION_SYSTEM_COMMON: CABBAGE LOOPER; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7111 KEYWDS PROTEIN TYROSINE KINASE, TRANSFERASE, ATP BINDING EXPDTA X-RAY DIFFRACTION AUTHOR D.MUSIL REVDAT 2 13-SEP-23 4GU9 1 REMARK SEQADV REVDAT 1 04-SEP-13 4GU9 0 JRNL AUTH T.HEINRICH,J.SEENISAMY,L.EMMANUVEL,S.S.KULKARNI,J.BOMKE, JRNL AUTH 2 F.ROHDICH,H.GREINER,C.ESDAR,M.KRIER,U.GRADLER,D.MUSIL JRNL TITL FRAGMENT-BASED DISCOVERY OF NEW HIGHLY SUBSTITUTED JRNL TITL 2 1H-PYRROLO[2,3-B]- AND 3H-IMIDAZOLO[4,5-B]-PYRIDINES AS JRNL TITL 3 FOCAL ADHESION KINASE INHIBITORS. JRNL REF J.MED.CHEM. V. 56 1160 2013 JRNL REFN ISSN 0022-2623 JRNL PMID 23294348 JRNL DOI 10.1021/JM3016014 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.1 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 22727 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.180 REMARK 3 R VALUE (WORKING SET) : 0.178 REMARK 3 FREE R VALUE : 0.221 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.130 REMARK 3 FREE R VALUE TEST SET COUNT : 1165 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 11 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.52 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.75 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2954 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.1879 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2788 REMARK 3 BIN R VALUE (WORKING SET) : 0.1839 REMARK 3 BIN FREE R VALUE : 0.2528 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.62 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 166 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4079 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 34 REMARK 3 SOLVENT ATOMS : 133 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 49.41 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 45.93 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.24290 REMARK 3 B22 (A**2) : -0.01180 REMARK 3 B33 (A**2) : -1.23110 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.286 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.366 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.943 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.923 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4210 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 5691 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1476 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 93 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 601 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4210 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 538 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 4721 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.10 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.09 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 18.19 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: A 414 A 685 REMARK 3 ORIGIN FOR THE GROUP (A): 8.6635 19.6507 -34.3308 REMARK 3 T TENSOR REMARK 3 T11: -0.1176 T22: -0.0803 REMARK 3 T33: -0.1039 T12: 0.0381 REMARK 3 T13: 0.0064 T23: 0.0639 REMARK 3 L TENSOR REMARK 3 L11: 1.4325 L22: 1.3436 REMARK 3 L33: 2.4225 L12: 0.8389 REMARK 3 L13: -0.8602 L23: -1.0858 REMARK 3 S TENSOR REMARK 3 S11: -0.0127 S12: 0.2050 S13: 0.1485 REMARK 3 S21: -0.0690 S22: 0.0998 S23: 0.0611 REMARK 3 S31: -0.0317 S32: -0.3103 S33: -0.0870 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: B 415 B 683 REMARK 3 ORIGIN FOR THE GROUP (A): 17.8154 -0.2868 -2.8902 REMARK 3 T TENSOR REMARK 3 T11: -0.0595 T22: -0.0772 REMARK 3 T33: -0.0890 T12: 0.0136 REMARK 3 T13: -0.0154 T23: 0.0049 REMARK 3 L TENSOR REMARK 3 L11: 1.1928 L22: 1.9300 REMARK 3 L33: 0.8576 L12: 0.3994 REMARK 3 L13: -0.1531 L23: -0.5008 REMARK 3 S TENSOR REMARK 3 S11: -0.0207 S12: -0.1197 S13: -0.0246 REMARK 3 S21: 0.0039 S22: 0.0576 S23: -0.0104 REMARK 3 S31: 0.0865 S32: -0.0059 S33: -0.0369 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4GU9 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-SEP-12. REMARK 100 THE DEPOSITION ID IS D_1000074639. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-JUL-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : PSI PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22728 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 44.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 6.500 REMARK 200 R MERGE (I) : 0.09100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.56 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 6.80 REMARK 200 R MERGE FOR SHELL (I) : 0.45600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 5.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 3PXK REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.04 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.20 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M TRIS, 16% PEG3350, PH 8.6, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 23.27050 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 68.38050 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 44.14400 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 68.38050 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 23.27050 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 44.14400 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 408 REMARK 465 SER A 409 REMARK 465 PRO A 410 REMARK 465 SER A 411 REMARK 465 THR A 412 REMARK 465 ARG A 413 REMARK 465 GLU A 445 REMARK 465 ASN A 446 REMARK 465 GLY A 566 REMARK 465 LEU A 567 REMARK 465 SER A 568 REMARK 465 ARG A 569 REMARK 465 TYR A 570 REMARK 465 MET A 571 REMARK 465 GLU A 572 REMARK 465 ASP A 573 REMARK 465 SER A 574 REMARK 465 THR A 575 REMARK 465 TYR A 576 REMARK 465 TYR A 577 REMARK 465 LYS A 578 REMARK 465 ALA A 579 REMARK 465 SER A 580 REMARK 465 LYS A 581 REMARK 465 GLY A 582 REMARK 465 LYS A 583 REMARK 465 GLN A 686 REMARK 465 GLY B 408 REMARK 465 SER B 409 REMARK 465 PRO B 410 REMARK 465 SER B 411 REMARK 465 THR B 412 REMARK 465 ARG B 413 REMARK 465 ASP B 414 REMARK 465 GLU B 445 REMARK 465 ASN B 446 REMARK 465 GLU B 572 REMARK 465 ASP B 573 REMARK 465 SER B 574 REMARK 465 THR B 575 REMARK 465 TYR B 576 REMARK 465 TYR B 577 REMARK 465 LYS B 578 REMARK 465 ALA B 579 REMARK 465 SER B 580 REMARK 465 LYS B 581 REMARK 465 GLY B 582 REMARK 465 LYS B 583 REMARK 465 LYS B 684 REMARK 465 ALA B 685 REMARK 465 GLN B 686 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 448 94.25 -28.69 REMARK 500 ARG A 545 -11.95 76.10 REMARK 500 ASP A 546 58.30 -144.78 REMARK 500 ALA B 448 73.08 -107.79 REMARK 500 ARG B 545 -13.81 78.11 REMARK 500 ASP B 546 59.96 -144.36 REMARK 500 GLU B 682 -10.43 -142.61 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 4GU A 701 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 4GU B 701 DBREF 4GU9 A 410 686 UNP Q05397 FAK1_HUMAN 410 686 DBREF 4GU9 B 410 686 UNP Q05397 FAK1_HUMAN 410 686 SEQADV 4GU9 GLY A 408 UNP Q05397 EXPRESSION TAG SEQADV 4GU9 SER A 409 UNP Q05397 EXPRESSION TAG SEQADV 4GU9 GLY B 408 UNP Q05397 EXPRESSION TAG SEQADV 4GU9 SER B 409 UNP Q05397 EXPRESSION TAG SEQRES 1 A 279 GLY SER PRO SER THR ARG ASP TYR GLU ILE GLN ARG GLU SEQRES 2 A 279 ARG ILE GLU LEU GLY ARG CYS ILE GLY GLU GLY GLN PHE SEQRES 3 A 279 GLY ASP VAL HIS GLN GLY ILE TYR MET SER PRO GLU ASN SEQRES 4 A 279 PRO ALA LEU ALA VAL ALA ILE LYS THR CYS LYS ASN CYS SEQRES 5 A 279 THR SER ASP SER VAL ARG GLU LYS PHE LEU GLN GLU ALA SEQRES 6 A 279 LEU THR MET ARG GLN PHE ASP HIS PRO HIS ILE VAL LYS SEQRES 7 A 279 LEU ILE GLY VAL ILE THR GLU ASN PRO VAL TRP ILE ILE SEQRES 8 A 279 MET GLU LEU CYS THR LEU GLY GLU LEU ARG SER PHE LEU SEQRES 9 A 279 GLN VAL ARG LYS TYR SER LEU ASP LEU ALA SER LEU ILE SEQRES 10 A 279 LEU TYR ALA TYR GLN LEU SER THR ALA LEU ALA TYR LEU SEQRES 11 A 279 GLU SER LYS ARG PHE VAL HIS ARG ASP ILE ALA ALA ARG SEQRES 12 A 279 ASN VAL LEU VAL SER SER ASN ASP CYS VAL LYS LEU GLY SEQRES 13 A 279 ASP PHE GLY LEU SER ARG TYR MET GLU ASP SER THR TYR SEQRES 14 A 279 TYR LYS ALA SER LYS GLY LYS LEU PRO ILE LYS TRP MET SEQRES 15 A 279 ALA PRO GLU SER ILE ASN PHE ARG ARG PHE THR SER ALA SEQRES 16 A 279 SER ASP VAL TRP MET PHE GLY VAL CYS MET TRP GLU ILE SEQRES 17 A 279 LEU MET HIS GLY VAL LYS PRO PHE GLN GLY VAL LYS ASN SEQRES 18 A 279 ASN ASP VAL ILE GLY ARG ILE GLU ASN GLY GLU ARG LEU SEQRES 19 A 279 PRO MET PRO PRO ASN CYS PRO PRO THR LEU TYR SER LEU SEQRES 20 A 279 MET THR LYS CYS TRP ALA TYR ASP PRO SER ARG ARG PRO SEQRES 21 A 279 ARG PHE THR GLU LEU LYS ALA GLN LEU SER THR ILE LEU SEQRES 22 A 279 GLU GLU GLU LYS ALA GLN SEQRES 1 B 279 GLY SER PRO SER THR ARG ASP TYR GLU ILE GLN ARG GLU SEQRES 2 B 279 ARG ILE GLU LEU GLY ARG CYS ILE GLY GLU GLY GLN PHE SEQRES 3 B 279 GLY ASP VAL HIS GLN GLY ILE TYR MET SER PRO GLU ASN SEQRES 4 B 279 PRO ALA LEU ALA VAL ALA ILE LYS THR CYS LYS ASN CYS SEQRES 5 B 279 THR SER ASP SER VAL ARG GLU LYS PHE LEU GLN GLU ALA SEQRES 6 B 279 LEU THR MET ARG GLN PHE ASP HIS PRO HIS ILE VAL LYS SEQRES 7 B 279 LEU ILE GLY VAL ILE THR GLU ASN PRO VAL TRP ILE ILE SEQRES 8 B 279 MET GLU LEU CYS THR LEU GLY GLU LEU ARG SER PHE LEU SEQRES 9 B 279 GLN VAL ARG LYS TYR SER LEU ASP LEU ALA SER LEU ILE SEQRES 10 B 279 LEU TYR ALA TYR GLN LEU SER THR ALA LEU ALA TYR LEU SEQRES 11 B 279 GLU SER LYS ARG PHE VAL HIS ARG ASP ILE ALA ALA ARG SEQRES 12 B 279 ASN VAL LEU VAL SER SER ASN ASP CYS VAL LYS LEU GLY SEQRES 13 B 279 ASP PHE GLY LEU SER ARG TYR MET GLU ASP SER THR TYR SEQRES 14 B 279 TYR LYS ALA SER LYS GLY LYS LEU PRO ILE LYS TRP MET SEQRES 15 B 279 ALA PRO GLU SER ILE ASN PHE ARG ARG PHE THR SER ALA SEQRES 16 B 279 SER ASP VAL TRP MET PHE GLY VAL CYS MET TRP GLU ILE SEQRES 17 B 279 LEU MET HIS GLY VAL LYS PRO PHE GLN GLY VAL LYS ASN SEQRES 18 B 279 ASN ASP VAL ILE GLY ARG ILE GLU ASN GLY GLU ARG LEU SEQRES 19 B 279 PRO MET PRO PRO ASN CYS PRO PRO THR LEU TYR SER LEU SEQRES 20 B 279 MET THR LYS CYS TRP ALA TYR ASP PRO SER ARG ARG PRO SEQRES 21 B 279 ARG PHE THR GLU LEU LYS ALA GLN LEU SER THR ILE LEU SEQRES 22 B 279 GLU GLU GLU LYS ALA GLN HET 4GU A 701 17 HET 4GU B 701 17 HETNAM 4GU N-(2-FLUOROPHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE FORMUL 3 4GU 2(C11 H8 F N5) FORMUL 5 HOH *133(H2 O) HELIX 1 1 GLN A 418 GLU A 420 5 3 HELIX 2 2 SER A 461 ARG A 476 1 16 HELIX 3 3 LEU A 507 ARG A 514 1 8 HELIX 4 4 ASP A 519 LYS A 540 1 22 HELIX 5 5 ALA A 548 ARG A 550 5 3 HELIX 6 6 PRO A 585 MET A 589 5 5 HELIX 7 7 ALA A 590 ARG A 597 1 8 HELIX 8 8 THR A 600 MET A 617 1 18 HELIX 9 9 LYS A 627 ASN A 629 5 3 HELIX 10 10 ASP A 630 ASN A 637 1 8 HELIX 11 11 PRO A 648 TRP A 659 1 12 HELIX 12 12 ASP A 662 ARG A 666 5 5 HELIX 13 13 ARG A 668 ALA A 685 1 18 HELIX 14 14 GLN B 418 GLU B 420 5 3 HELIX 15 15 SER B 461 ARG B 476 1 16 HELIX 16 16 LEU B 507 ARG B 514 1 8 HELIX 17 17 ASP B 519 LYS B 540 1 22 HELIX 18 18 ALA B 548 ARG B 550 5 3 HELIX 19 19 LEU B 567 MET B 571 5 5 HELIX 20 20 PRO B 585 MET B 589 5 5 HELIX 21 21 ALA B 590 ARG B 597 1 8 HELIX 22 22 THR B 600 MET B 617 1 18 HELIX 23 23 LYS B 627 ASN B 637 1 11 HELIX 24 24 PRO B 648 TRP B 659 1 12 HELIX 25 25 ASP B 662 ARG B 666 5 5 HELIX 26 26 ARG B 668 GLU B 681 1 14 SHEET 1 A 5 ILE A 422 GLU A 430 0 SHEET 2 A 5 ASP A 435 TYR A 441 -1 O GLN A 438 N ARG A 426 SHEET 3 A 5 LEU A 449 THR A 455 -1 O ILE A 453 N HIS A 437 SHEET 4 A 5 TRP A 496 GLU A 500 -1 O MET A 499 N ALA A 452 SHEET 5 A 5 LEU A 486 ILE A 490 -1 N GLY A 488 O ILE A 498 SHEET 1 B 3 GLY A 505 GLU A 506 0 SHEET 2 B 3 VAL A 552 SER A 556 -1 O VAL A 554 N GLY A 505 SHEET 3 B 3 CYS A 559 LEU A 562 -1 O LYS A 561 N LEU A 553 SHEET 1 C 5 ILE B 422 GLU B 430 0 SHEET 2 C 5 ASP B 435 MET B 442 -1 O GLN B 438 N ARG B 426 SHEET 3 C 5 ALA B 448 THR B 455 -1 O ILE B 453 N HIS B 437 SHEET 4 C 5 TRP B 496 GLU B 500 -1 O ILE B 497 N LYS B 454 SHEET 5 C 5 LEU B 486 ILE B 490 -1 N GLY B 488 O ILE B 498 SHEET 1 D 3 GLY B 505 GLU B 506 0 SHEET 2 D 3 VAL B 552 SER B 556 -1 O VAL B 554 N GLY B 505 SHEET 3 D 3 CYS B 559 LEU B 562 -1 O LYS B 561 N LEU B 553 SSBOND 1 CYS A 456 CYS A 459 1555 1555 2.04 SSBOND 2 CYS B 456 CYS B 459 1555 1555 2.04 CISPEP 1 ASN A 493 PRO A 494 0 -3.09 CISPEP 2 ASN B 493 PRO B 494 0 -2.14 SITE 1 AC1 8 ILE A 428 VAL A 436 ALA A 452 VAL A 484 SITE 2 AC1 8 MET A 499 GLU A 500 CYS A 502 LEU A 553 SITE 1 AC2 9 ILE B 428 GLY B 429 VAL B 436 ALA B 452 SITE 2 AC2 9 VAL B 484 MET B 499 GLU B 500 CYS B 502 SITE 3 AC2 9 LEU B 553 CRYST1 46.541 88.288 136.761 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021486 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011327 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007312 0.00000